checkAd

     105  0 Kommentare Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center - Seite 3

    Lesen Sie auch


    The Biodesix Stock at the time of publication of the news with a raise of +2,22 % to 1,380USD on Nasdaq stock exchange (23. März 2024, 01:00 Uhr).

    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center - Seite 3 Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung diseases, today announced that it has entered into a new master collaborative research agreement (MCRA) with Memorial Sloan Kettering Cancer Center (MSK) …